Through the correlation study between gene expression changes and clinical indicators, it was found that PACSIN1 can be used as an independent prognostic molecule of gliomas, and can predict the prognosis and development of patients’ disease to a certain extent, which will be a potential new site for targeted therapy of gliomas. This evidence concerns the gene PACSIN1 and glioma.